# A.K.A. Brands Holding Corp.: financial statements, quarterly

AKA · NYSE · CIK 1865107 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aka.md) · [Financials](/companies/aka/financials.md) · [Filings](/companies/aka/filings.md) · [Insiders](/companies/aka/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aka/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [141](/filings/0001865107-24-000086.md) | [149 d](/filings/0001865107-26-000008.md) | [117](/filings/0001865107-25-000031.md) | [149](/filings/0001865107-25-000059.md) | [150](/filings/0001865107-25-000072.md) | [159 d](/filings/0001865107-26-000008.md) | [129](/filings/0001865107-26-000028.md) | [161](/filings/0001865107-26-000044.md) | [147](/filings/0001865107-25-000072.md) | [164 d](/filings/0001865107-26-000008.md) | [132](/filings/0001865107-26-000028.md) | [160](/filings/0001865107-26-000044.md) |
| Cost of revenue | $m | [62.9](/filings/0001865107-24-000086.md) | [72.5 d](/filings/0001865107-26-000008.md) | [51.2](/filings/0001865107-25-000031.md) | [63.0](/filings/0001865107-25-000059.md) | [63.0](/filings/0001865107-25-000072.md) | [70.1 d](/filings/0001865107-26-000008.md) | [55.0](/filings/0001865107-26-000028.md) | [68.2](/filings/0001865107-26-000044.md) | [60.1](/filings/0001865107-25-000072.md) | [72.9 d](/filings/0001865107-26-000008.md) | [48.8](/filings/0001865107-26-000028.md) | [62.2](/filings/0001865107-26-000044.md) |
| Gross profit | $m | [78.0](/filings/0001865107-24-000086.md) | [76.5 d](/filings/0001865107-26-000008.md) | [65.7](/filings/0001865107-25-000031.md) | [86.0](/filings/0001865107-25-000059.md) | [86.9](/filings/0001865107-25-000072.md) | [88.9 d](/filings/0001865107-26-000008.md) | [73.7](/filings/0001865107-26-000028.md) | [92.3](/filings/0001865107-26-000044.md) | [87.0](/filings/0001865107-25-000072.md) | [91.1 d](/filings/0001865107-26-000008.md) | [83.6](/filings/0001865107-26-000028.md) | [97.8](/filings/0001865107-26-000044.md) |
| Operating income | $m | [(70.3)](/filings/0001865107-24-000086.md) | [(5.4) d](/filings/0001865107-26-000008.md) | [(6.1)](/filings/0001865107-25-000031.md) | [0.6](/filings/0001865107-25-000059.md) | [(2.1)](/filings/0001865107-25-000072.md) | [(2.8) d](/filings/0001865107-26-000008.md) | [(5.4)](/filings/0001865107-26-000028.md) | [(0.5)](/filings/0001865107-26-000044.md) | [(1.4)](/filings/0001865107-25-000072.md) | [(10.7) d](/filings/0001865107-26-000008.md) | [(4.1)](/filings/0001865107-26-000028.md) | [1.2](/filings/0001865107-26-000044.md) |
| Interest expense | $m | [2.8](/filings/0001865107-23-000076.md) | [2.7 d](/filings/0001865107-24-000010.md) | [2.3](/filings/0001865107-24-000045.md) | [2.7](/filings/0001865107-24-000075.md) | [2.7](/filings/0001865107-25-000072.md) | [2.6 d](/filings/0001865107-26-000008.md) | [2.7](/filings/0001865107-26-000028.md) | [2.5](/filings/0001865107-26-000044.md) | [2.4](/filings/0001865107-25-000072.md) | [2.5 d](/filings/0001865107-26-000008.md) | [2.2](/filings/0001865107-26-000028.md) | [2.2](/filings/0001865107-26-000044.md) |
| Income tax | $m | [(3.3)](/filings/0001865107-24-000086.md) | [5.8 d](/filings/0001865107-26-000008.md) | [0.0](/filings/0001865107-25-000031.md) | [0.5](/filings/0001865107-25-000059.md) | [(0.1)](/filings/0001865107-25-000072.md) | [3.9 d](/filings/0001865107-26-000008.md) | [0.0](/filings/0001865107-26-000028.md) | [0.0](/filings/0001865107-26-000044.md) | [0.9](/filings/0001865107-25-000072.md) | [1.2 d](/filings/0001865107-26-000008.md) | [0.2](/filings/0001865107-26-000028.md) | [(0.1)](/filings/0001865107-26-000044.md) |
| Net income | $m | [(70.4)](/filings/0001865107-24-000086.md) | [(13.9) d](/filings/0001865107-26-000008.md) | [(8.9)](/filings/0001865107-25-000031.md) | [(2.3)](/filings/0001865107-25-000059.md) | [(5.4)](/filings/0001865107-25-000072.md) | [(9.4) d](/filings/0001865107-26-000008.md) | [(8.4)](/filings/0001865107-26-000044.md) | [(3.6)](/filings/0001865107-26-000044.md) | [(5.0)](/filings/0001865107-25-000072.md) | [(14.5) d](/filings/0001865107-26-000008.md) | [(7.1)](/filings/0001865107-26-000044.md) | [(0.2)](/filings/0001865107-26-000044.md) |
| Diluted EPS | $ per share | [(6.58)](/filings/0001865107-24-000086.md) | not reported | [(0.85)](/filings/0001865107-25-000031.md) | [(0.22)](/filings/0001865107-25-000059.md) | [(0.51)](/filings/0001865107-25-000072.md) | not reported | [(0.78)](/filings/0001865107-26-000028.md) | [(0.34)](/filings/0001865107-26-000044.md) | [(0.46)](/filings/0001865107-25-000072.md) | not reported | [(0.66)](/filings/0001865107-26-000028.md) | [(0.01)](/filings/0001865107-26-000044.md) |
| Basic EPS | $ per share | [(6.58)](/filings/0001865107-24-000086.md) | not reported | [(0.85)](/filings/0001865107-25-000031.md) | [(0.22)](/filings/0001865107-25-000059.md) | [(0.51)](/filings/0001865107-25-000072.md) | not reported | [(0.78)](/filings/0001865107-26-000028.md) | [(0.34)](/filings/0001865107-26-000044.md) | [(0.46)](/filings/0001865107-25-000072.md) | not reported | [(0.66)](/filings/0001865107-26-000028.md) | [(0.01)](/filings/0001865107-26-000044.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [20.7](/filings/0001865107-23-000076.md) | [21.9](/filings/0001865107-25-000016.md) | [21.9](/filings/0001865107-24-000045.md) | [25.5](/filings/0001865107-24-000075.md) | [23.1](/filings/0001865107-24-000086.md) | [24.2](/filings/0001865107-26-000008.md) | [26.7](/filings/0001865107-25-000031.md) | [23.1](/filings/0001865107-25-000059.md) | [23.4](/filings/0001865107-25-000072.md) | [20.3](/filings/0001865107-26-000044.md) | [12.9](/filings/0001865107-26-000028.md) | [21.1](/filings/0001865107-26-000044.md) |
| Current assets | $m | [154](/filings/0001865107-23-000076.md) | [136](/filings/0001865107-25-000016.md) | [134](/filings/0001865107-24-000045.md) | [155](/filings/0001865107-24-000075.md) | [156](/filings/0001865107-24-000086.md) | [145](/filings/0001865107-26-000008.md) | [149](/filings/0001865107-25-000031.md) | [155](/filings/0001865107-25-000059.md) | [145](/filings/0001865107-25-000072.md) | [129](/filings/0001865107-26-000044.md) | [125](/filings/0001865107-26-000028.md) | [124](/filings/0001865107-26-000044.md) |
| Total assets | $m | [378](/filings/0001865107-23-000076.md) | [362](/filings/0001865107-25-000016.md) | [356](/filings/0001865107-24-000045.md) | [389](/filings/0001865107-24-000075.md) | [404](/filings/0001865107-24-000086.md) | [385](/filings/0001865107-26-000008.md) | [397](/filings/0001865107-25-000031.md) | [411](/filings/0001865107-25-000059.md) | [411](/filings/0001865107-25-000072.md) | [397](/filings/0001865107-26-000044.md) | [398](/filings/0001865107-26-000028.md) | [405](/filings/0001865107-26-000044.md) |
| Current liabilities | $m | [88.1](/filings/0001865107-23-000076.md) | [86.0](/filings/0001865107-25-000016.md) | [82.5](/filings/0001865107-24-000045.md) | [99.8](/filings/0001865107-24-000075.md) | [98.8](/filings/0001865107-24-000086.md) | [97.0](/filings/0001865107-26-000008.md) | [98.0](/filings/0001865107-25-000031.md) | [117](/filings/0001865107-25-000059.md) | [108](/filings/0001865107-25-000072.md) | [105](/filings/0001865107-26-000044.md) | [106](/filings/0001865107-26-000028.md) | [112](/filings/0001865107-26-000044.md) |
| Total liabilities | $m | [224](/filings/0001865107-23-000076.md) | [213](/filings/0001865107-25-000016.md) | [220](/filings/0001865107-24-000045.md) | [252](/filings/0001865107-24-000075.md) | [267](/filings/0001865107-24-000086.md) | [268](/filings/0001865107-26-000008.md) | [285](/filings/0001865107-25-000031.md) | [297](/filings/0001865107-25-000059.md) | [301](/filings/0001865107-25-000072.md) | [300](/filings/0001865107-26-000044.md) | [303](/filings/0001865107-26-000028.md) | [309](/filings/0001865107-26-000044.md) |
| Long-term debt | $m | [99.0](/filings/0001865107-23-000076.md) | [90.1](/filings/0001865107-25-000016.md) | [98.8](/filings/0001865107-24-000045.md) | [101](/filings/0001865107-24-000075.md) | [106](/filings/0001865107-24-000086.md) | [105](/filings/0001865107-26-000008.md) | [113](/filings/0001865107-25-000031.md) | [101](/filings/0001865107-25-000059.md) | [104](/filings/0001865107-25-000072.md) | [105](/filings/0001865107-26-000044.md) | [103](/filings/0001865107-26-000028.md) | [93.5](/filings/0001865107-26-000044.md) |
| Current portion of debt | $m | [7.7](/filings/0001865107-23-000076.md) | [3.3](/filings/0001865107-25-000016.md) | [4.7](/filings/0001865107-24-000045.md) | [6.3](/filings/0001865107-24-000075.md) | [6.3](/filings/0001865107-24-000086.md) | [6.3](/filings/0001865107-26-000008.md) | [7.0](/filings/0001865107-25-000031.md) | [7.7](/filings/0001865107-25-000059.md) | [7.7](/filings/0001865107-25-000072.md) | [6.4](/filings/0001865107-26-000044.md) | [6.4](/filings/0001865107-26-000028.md) | [6.4](/filings/0001865107-26-000044.md) |
| Shareholders' equity | $m | [154](/filings/0001865107-24-000086.md) | [149](/filings/0001865107-26-000008.md) | [136](/filings/0001865107-25-000072.md) | [137](/filings/0001865107-25-000072.md) | [137](/filings/0001865107-25-000072.md) | [118](/filings/0001865107-26-000044.md) | [111](/filings/0001865107-26-000044.md) | [114](/filings/0001865107-26-000044.md) | [110](/filings/0001865107-25-000072.md) | [97.8](/filings/0001865107-26-000044.md) | [94.4](/filings/0001865107-26-000044.md) | [95.6](/filings/0001865107-26-000044.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [10.8 d](/filings/0001865107-24-000086.md) | [15.4 d](/filings/0001865107-26-000008.md) | [(7.7)](/filings/0001865107-25-000031.md) | [3.5 d](/filings/0001865107-25-000059.md) | [(2.1) d](/filings/0001865107-25-000072.md) | [7.0 d](/filings/0001865107-26-000008.md) | [(1.9)](/filings/0001865107-26-000028.md) | [11.9 d](/filings/0001865107-26-000044.md) | [4.7 d](/filings/0001865107-25-000072.md) | [1.7 d](/filings/0001865107-26-000008.md) | [(3.8)](/filings/0001865107-26-000028.md) | [22.6 d](/filings/0001865107-26-000044.md) |
| Capital expenditure | $m | [1.8 d](/filings/0001865107-24-000086.md) | [0.5 d](/filings/0001865107-26-000008.md) | [0.8](/filings/0001865107-25-000031.md) | [2.0 d](/filings/0001865107-25-000059.md) | [5.0 d](/filings/0001865107-25-000072.md) | [3.9 d](/filings/0001865107-26-000008.md) | [3.4](/filings/0001865107-26-000028.md) | [4.5 d](/filings/0001865107-26-000044.md) | [4.4 d](/filings/0001865107-25-000072.md) | [4.7 d](/filings/0001865107-26-000008.md) | [2.6](/filings/0001865107-26-000028.md) | [4.3 d](/filings/0001865107-26-000044.md) |
| Share repurchases | $m | [0.6 d](/filings/0001865107-24-000086.md) | [1.2 d](/filings/0001865107-26-000008.md) | [1.1](/filings/0001865107-25-000031.md) | [0.1 d](/filings/0001865107-25-000059.md) | [0.1 d](/filings/0001865107-25-000072.md) | [0.2 d](/filings/0001865107-26-000008.md) | [0.3](/filings/0001865107-26-000028.md) | [0.1 d](/filings/0001865107-26-000044.md) | [1.6 d](/filings/0001865107-25-000072.md) | [0.0 d](/filings/0001865107-26-000008.md) | [0.0](/filings/0001865107-26-000028.md) | [0.0 d](/filings/0001865107-26-000044.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.7](/filings/0001865107-23-000076.md) | [10.8](/filings/0001865107-24-000045.md) | [10.8](/filings/0001865107-24-000075.md) | [10.7](/filings/0001865107-24-000086.md) | [10.5](/filings/0001865107-25-000031.md) | [10.5](/filings/0001865107-25-000059.md) | [10.6](/filings/0001865107-25-000072.md) | [10.7](/filings/0001865107-26-000028.md) | [10.7](/filings/0001865107-26-000044.md) | [10.7](/filings/0001865107-25-000072.md) | [10.8](/filings/0001865107-26-000028.md) | [10.9](/filings/0001865107-26-000044.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 10,991,059 at 2026-08-04, from the cover of the [10-Q filed 2026-08-05](/filings/0001865107-26-000044.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.